MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

By

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alexander Soule

Analyst: Boston Scientific could take pacer lead

Boston Scientific might lack a truly leadless pacemaker, unlike rivals Medtronic and St. Jude Medical, but it still might be in the best position to gain share in the cardiac rhythm management market, according to Leerink Swann analyst Danielle Antalffy.

Traditional pacemakers are inserted adjacent to the heart and use “leads” to deliver impulses to maintain regular heartbeat. St. Jude acquired a “leadless” pacemaker when it acquired Nanostim in October 2013, with Medtronic seeking approval for its own Micra version of the the technology. Read more

Orthofix CFO bails after 6 months amid deepening financial fix

September 25, 2014 by Alexander Soule

Orthofix CFO bails after 6 months amid financial fix

Orthofix CFO Mark Heggestad is stepping down just 6 months into his tenure, even as the medical device company’s 3-year financial restatement yesterday deepened on new problems with its inventory controls.

Orthofix promoted its chief accounting officer Doug Rice to replace Heggestad, who took over May 9 from interim CFO David Ziegler. Longtime CFO Emily Buxton had been replaced in April after a decade as Orthofix’s financial chief. Heggestad, who is slated to stay on as an outside consultant, is leaving due to “personal circumstances,” Orthofix said. Read more

Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien

September 29, 2014 by Brad Perriello

Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien

After 3 rejections, the FDA approved the Iluvien diabetic macular degeneration drug/device treatment co-developed by Alimera Sciences and pSivida, sending both companies’ stock up today on Wall Street.

Iluvien, an injectable implant, was approved to treat DME, a swelling on the back of the retina that in the most severe cases can lead to blindness. It’s a tiny cylinder implanted in the back of the eye that’s designed to deliver small doses of a corticosteroid, fluocinolone acetonide, for 36 months. Read more

Echo Therapeutics is on the ropes

September 25, 2014 by Alexander Soule

Echo Therapeutics is on the ropes

After warning in August it had sufficient capital to last it only until November, Echo Therapeutics abruptly suspended operations, saying its cash resources will be drained by the end of September and raising the specter of a bankruptcy filing.

Philadelphia-based Echo Therapeutics has been developing a wireless system it calls Symphony for the continuous monitoring of blood glucose levels in hospitals.  Read more

Activist investor erupts at Volcano

September 30, 2014 by Alexander Soule

Activist investor erupts at Volcano

A California activist investor upped its pressure on Volcano yesterday, scolding the company for its $115 million AtheroMed acquisition and missing chances to sell itself at a premium, and threatening a move to oust chairman Ron Matricaria and CEO Scott Huennekens.

San Diego-based Volcano makes precision-guided medical devices, including intravascular ultrasound systems to gauge potential blockages in blood vessels, and functional measurement guidewires to analyze pressure and flow parameters from inside a vessel. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits
    Steris (NYSE: STE) stock was downgraded today by Needham from buy to hold following the $363 million jury verdict against its primary competitor, Sterigenics, over ethylene oxide (EtO) emissions. Needham analysts said they expect attorneys to target communities near EtO facilities with ads to find people willing to file more lawsuits against sterilization plant operators… […]
  • Researchers develop at-home device to track Parkinson’s progression
    Researchers at MIT and the University of Rochester Medical Center have developed a device to monitor a Parkinson’s patient at home. Collecting data at home could help provide a less subjective measurement than evaluations at the doctor’s office, which can be affected by outside factors. The technology could also help pharmaceutical and biotech companies developing… […]
  • Micro Mold renovates for new 5-axis milling center
    Precision mold maker Micro Mold has renovated in Erie, Pennsylvania, to make room for its new Yasda YMC650 high-speed 5-axis milling center and 3R Workpartner automation cell. The new equipment will be used for electrode manufacturing and finishing hard mill applications. The milling machine is accurate to 1 micron for high-volume, ultra-precision tooling work, the… […]
  • September 2022 Issue: The Medtech Big 100 is bigger than ever
    Medtech sales reach a record high as R&D spend and employee counts climb Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future Autotransfusion device maker ships units to Ukraine How IP protection is enabling robotic surgery innovation Connected device design for the real world: Managing the development process FDA details plans to expand… […]
  • How NeuroOne and Zimmer Biomet will partner on robotic brain surgery
    NeuroOne (NASDAQ: NMTC) is preparing its depth electrode technology for commercialization through Zimmer Biomet (NYSE: ZBH) while waiting for FDA feedback on its latest submission. NeuroOne’s Evo stereoelectroencephalography (sEEG) device won FDA 510(k) clearance in September 2021 for recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. That clearance was… […]
  • Trelleborg to show off advanced polymer tech at MD&M Minneapolis
    Trelleborg Healthcare & Medical will exhibit advanced polymer technologies for medical applications at MD&M Minneapolis, which runs Nov. 2–3, 2022. The Sweden-based engineering polymer giant, which has operations in 50 companies, has newly acquired, advanced capabilities in thermoplastic injection molding. The new injection molding capabilities come from its purchase of Menomonie, Wisconsin–based EirMed earlier this… […]
  • Millstone Medical Outsourcing expands cleanroom facility
    Millstone Medical Outsourcing said today that it has broken ground on a 5,000-square-foot cleanroom facility expansion at its Fall River, Massachusetts headquarters. The project is Millstone’s third cleanroom expansion. The additional Class 10,000/ISO7-rated cleanroom space is for medical device packaging operations. It will bring the company’s total cleanroom footprint to 20,000 square feet. Responding to… […]
  • Johnson & Johnson launches Bay Area science and technology campus
    Johnson & Johnson (NYSE:JNJ) has opened an almost 200,000 ft2 science and technology campus in the San Francisco Bay Area. The new facility more than doubles the presence of the company in the Bay Area, which has been a hub for life sciences innovation for decades. Up to 400 employees will work at the facility. “This… […]
  • VitalPath opens new Design Center in Minnesota
    VitalPath announced today that it recently opened a new Design Center in the Minneapolis suburb of New Hope. The Minnesota-based company manufactures custom, highly complex catheter solutions for major medical device companies. It says the new Design Center brings its entire design and prototyping capabilities under one roof in order to accelerate time to market.… […]
  • Currier Plastics buys building to expand capacity
    Currier Plastics has purchased a 71,000 ft² building to expand its capacity for healthcare customers. The Auburn, New York-based plastics manufacturer has already started building out the former TRW Automotive plant in Aurelius, New York. Construction is expected to be done in Q1 2023. The building will have 25,000 ft² of ISO Class 8 cleanroom… […]
  • Jury awards $363M verdict in Sterigenics ethylene oxide lawsuit
    An Illinois jury has awarded $363 million in a lawsuit that blamed a Sterigenics sterilization facility’s emissions of ethylene oxide for a woman’s breast cancer and her son’s non-Hodgkin’s lymphoma. It’s the first verdict in hundreds of lawsuits against Oak Brook, Illinois-based Sterigenics, which permanently closed the Willowbrook, Illinois facility in 2019 after state officials… […]

Leave a Reply